Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bausch & Lomb taking $10 mil. charge for settlement of lens marketing class action suit.

This article was originally published in The Gray Sheet

Executive Summary

BAUSCH & LOMB TO TAKE $10 MIL. CHARGE FOR CONTACT LENS CLASS ACTION SETTLEMENT, the company announced Aug. 1. The lawsuit, given class action status in Birmingham, Alabama on Nov. 1, 1994, related to the firm's marketing of its SeeQuence 2, Medalist, Optima FW and Criterion Ultra FW soft contact lenses.

You may also be interested in...



J&J AcuVue Class Action Settlement Immaterial Due To Existing Reserves

A proposed settlement of a Johnson & Johnson AcuVue contact lens class action suit valued at up to $860 mil. will not have a material impact on financial results due to existing litigation reserves, the firm says. A preliminary hearing on the settlement proposal, announced April 17, is set for May 18.

Device Week, 4 December 2020 – MedWatch Question About Third-Party Servicers Slides Under Industry's Radar

On this week’s podcast: A change made by the US FDA to its MedWatch program that asks adverse event reporters whether a third party serviced a malfunctioning medical device went unnoticed by many in industry for nearly a year. We explain why, and tell how the servicer question will be helpful for manufacturers and the agency.

UsernamePublicRestriction

Register

ID1132679

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel